Apollo Hospitals Reports Q4FY26 Results; PAT Jumps To Rs 551 Crore, Announces Rs 10 Dividend

On Thursday, the Indian equity benchmarks traded higher in early trade, with the Nifty 50 index gaining 0.60 per cent to trade above the 23,800 mark amid buying interest in healthcare and financial stocks. Apollo Hospitals Enterprise share price remained in focus after the company announced its Q4FY26 and FY26 financial results along with a final Dividend recommendation for shareholders.

Q4FY26 Performance

Apollo Hospitals reported consolidated revenue from operations of Rs 6,606 crore in Q4FY26 as against Rs 5,592 crore reported in Q4FY25, registering a growth of around 18.1 per cent YoY. EBITDA stood at Rs 1,011 crore during the quarter compared to Rs 770 crore reported in the corresponding quarter previous year, reflecting a growth of around 31.3 per cent YoY.

Profit before Tax came in at Rs 722 crore in Q4FY26 as against Rs 516 crore reported in Q4FY25, registering a growth of around 39.9 per cent YoY. Net profit stood at Rs 551 crore during Q4FY26 compared to Rs 414 crore reported in the corresponding quarter previous year, reflecting a growth of around 33.1 per cent YoY.

On a sequential basis, revenue increased from Rs 6,477 crore in Q3FY26 to Rs 6,606 crore in Q4FY26, while net profit rose from Rs 516 crore to Rs 551 crore during the same period.

FY26 Financial Highlights

For the financial year ended March 31, 2026, Apollo Hospitals reported consolidated revenue of Rs 25,229 crore as against Rs 21,794 crore reported in FY25, registering a growth of around 15.8 per cent YoY. EBITDA increased to Rs 3,769 crore during FY26 compared to Rs 3,033 crore reported in the previous financial year.

Profit before tax for FY26 came in at Rs 2,661 crore as against Rs 2,039 crore reported in FY25, reflecting a growth of around 30.5 per cent YoY. Net profit stood at Rs 2,003 crore during FY26 compared to Rs 1,505 crore reported in FY25, registering a growth of around 33.1 per cent YoY.

The company’s earnings per share stood at Rs 135.04 during FY26 compared to Rs 100.56 reported in FY25. Operating profit margin improved to 15 per cent in FY26 from 14 per cent reported in the previous financial year.

Dividend Announcement

The board of directors recommended a final dividend of Rs 10 per equity share of face value Rs 5 each for FY26, translating into a dividend payout of 200 per cent. The proposed dividend is subject to approval of shareholders at the ensuing Annual General Meeting (AGM) of the company.

Operational Developments

Apollo HealthCo completed its first full year of profitability during FY26 while continuing to expand its pharmacy and digital health operations. The company stated that the proposed demerger of its pharmacy and digital health businesses is progressing, with the new entity expected to move towards a potential listing by Q4FY27, subject to regulatory and stakeholder approvals.

During the year, Apollo Health and Lifestyle Limited announced plans to combine with Kids Clinic India Limited, which operates under the ‘Cloudnine’ brand, to create a maternity and fertility care platform. The company also approved the merger of Apollo Hospitals North Limited with Apollo Hospitals Enterprise Ltd.

Apollo Hospitals further increased its stake in Apollo Health and Lifestyle Limited by acquiring shares held by International Finance Corporation and other shareholders, resulting in AHLL becoming a wholly owned subsidiary.

What are your views on Apollo Hospitals’ Q4FY26 performance and expansion across hospitals, pharmacy and digital healthcare businesses? Share your thoughts in the comments below.
Disclaimer: This article is for informational purposes only and not investment advice.